SRPK1 and prostate carcinoma: For instance, LIMK2 downregulated NKX3.1 to increase the oncogenicity of castration-resistant prostate cancer [23], and overexpressed LIMK2 exhibited as a facilitator of triple-negative breast cancer metastasis by regulating SRPK1 [24].